Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Genentech Inc.

(GNE)

Barbara Hoffman of Piper Jaffray said that positive data on

Pulmozyme

DNase presented at the North American Cystic Fibrosis Conference will

Read the full 252 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE